Short answer
OLAPLEX HOLDINGS, INC. (OLPX) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $115M (down 3.8% year over year) with net income of $11M.
Q3 2025 key financials · XBRL
- Revenue
- $115M
- −3.8% YoY · +7.8% QoQ
- Net income
- $11M
- −24.8% YoY · +243.7% QoQ
- Operating margin
- 3.7%
- Gross margin
- 69.1%
- EPS (diluted)
- $0.02
- +0.0% YoY · +300.0% QoQ
Source: XBRL data from the OLAPLEX HOLDINGS, INC. (OLPX) Q3 2025 10-Q on SEC EDGAR. USD.
OLAPLEX HOLDINGS, INC. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $114.6M, down 3.8% YoY from $119.1M
- Gross margin 69.1% vs 68.6% YoY; operating margin 3.7% vs 23.5%
- Best channel Professional revenue $44.5M, up 5.3%; worst Specialty retail $36.9M, down 13.5%
- Cash $286.4M; operating cash flow $26.0M vs $93.4M; $300.0M term-loan repayment
- Headwinds: competitive discounting, inflation, tariffs, currency volatility, and weaker discretionary spending risks
Risk Factors
- No risk-factors section provided; supplied text begins with Item 2
- Purvala Bioscience acquisition disclosed through August 20, 2025 stock purchase agreement
- No director or officer adopted or terminated Rule 10b5-1 arrangements during quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other OLAPLEX HOLDINGS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.